Somewhat Positive News Coverage Extremely Likely to Affect Syneron Medical (NASDAQ:ELOS) Stock Price

News headlines about Syneron Medical (NASDAQ:ELOS) have trended somewhat positive on Wednesday, Accern Sentiment reports. The research group identifies positive and negative press coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Syneron Medical earned a coverage optimism score of 0.15 on Accern’s scale. Accern also gave news coverage about the medical equipment provider an impact score of 100 out of 100, indicating that recent press coverage is extremely likely to have an impact on the stock’s share price in the next several days.

Syneron Medical (NASDAQ ELOS) remained flat at $11.00 during midday trading on Wednesday. 3,905 shares of the stock were exchanged. The firm’s market cap is $383.88 million. The stock’s 50-day moving average is $10.90 and its 200-day moving average is $10.14. Syneron Medical has a 52 week low of $6.18 and a 52 week high of $11.43.

A number of brokerages recently issued reports on ELOS. BidaskClub cut shares of Syneron Medical from a “hold” rating to a “sell” rating in a research report on Thursday, July 6th. Maxim Group cut shares of Syneron Medical from a “buy” rating to a “hold” rating and dropped their target price for the stock from $12.00 to $11.00 in a research report on Friday, May 12th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the company’s stock. Syneron Medical currently has an average rating of “Hold” and an average price target of $9.95.

WARNING: This report was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this report on another publication, it was illegally copied and republished in violation of international trademark & copyright laws. The original version of this report can be viewed at https://sportsperspectives.com/2017/07/20/syneron-medical-nasdaqelos-earning-somewhat-positive-press-coverage-analysis-shows-updated.html.

Syneron Medical Company Profile

Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company’s aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments.

Insider Buying and Selling by Quarter for Syneron Medical (NASDAQ:ELOS)

Receive News & Ratings for Syneron Medical Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneron Medical Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply